SEC Form 4 · accession 0001127602-18-022973
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Patusky
Director
Period of report
Jul 6, 2018
Accepted (ET)
Jul 9, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2018 | M | 3,500 | $51.77 | A | 6,870 | D | |
| Common Stock | Jul 6, 2018 | D | 3,500 | $120.29 | D | 3,370 | D | |
| Common Stock | holding | — | — | — | 1,300 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $51.77 | Jul 6, 2018 | M | 3,500 | D | Jun 28, 2011 | Jun 28, 2020 | Common Stock | 3,500 | 0 | D |
Explanation of responses
- F1This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.